Annual Report

Overview

The report describes a mixed but strategically active 2025: the HeROPA phase IIb study produced statistically significant inflammation findings, while a glaucoma pilot reported improved visual-field results. The nutraceutical business generated NOK 39.8 million in 2025 sales and launched Romega Skin Refine. Arctic Algae continued development work, and the Group ended the year with 20 employees.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services